List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1551 studies with search of: "Colorectal Neoplasms"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety Study of Radio-Labeled huA33 Antibody in Colorectal Cancer
Conditions: Colorectal Neoplasms;   Colorectal Cancer;   Colorectal Tumor;   Colorectal Carcinoma
Intervention: Drug: Iodine-124 labeled humanized A33 (antibody)
2 Completed Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
Conditions: Colorectal Cancer;   Colon Cancer;   Rectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma;   Colorectal Tumor
Intervention: Drug: hMN14 (labetuzumab)
3 Recruiting Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
Conditions: Colorectal Cancer;   Colorectal Neoplasm
Interventions: Procedure: Immunochemical fecal occult blood test;   Procedure: Colonoscopy
4 Completed Colorectal Cancer Screening Intervention Trial
Conditions: Colorectal Cancer;   Colorectal Cancer Screening
Interventions: Other: Control;   Other: Reduced out of pocket expense;   Behavioral: one on one education;   Behavioral: Group education
5 Recruiting Implementation of a New Strategy to Identify HNPCC Patients
Conditions: Colorectal Neoplasms;   Hereditary Nonpolyposis Colorectal Cancer
Interventions: Behavioral: Education for professionals;   Behavioral: Distribution of educational materials;   Behavioral: Feedback for professionals;   Behavioral: Reminders for professionals
6 Recruiting Phase I Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Conditions: Advanced Colorectal Cancer;   Metastatic Colorectal Cancer;   Responsive to Fluoropyrimidines
Interventions: Drug: lapatinib;   Drug: oxaliplatin;   Drug: capecitabine
7 Completed A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer
Conditions: Advanced Colorectal Cancer;   Colorectal Cancer
Intervention: Drug: CP-4055
8 Active, not recruiting Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Colon Cancer;   Colorectal Cancer;   Rectal Cancer
Interventions: Drug: Placebo;   Drug: AMG 655
9 Recruiting PEAK: A Phase 2 Study of Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer Subjects With Wild-Type KRAS Tumors
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: Bevacizumab;   Drug: mFOLFOX6
10 Recruiting New Individualized Therapy Trial for Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasm;   Colorectal Cancer
Interventions: Drug: Imatinib mesylate followed by a combination of imatinib mesylate & panitumumab;   Drug: Standard-of-care treatment with panitumumab
11 Enrolling by invitation Implementation of Guidelines on Hereditary or Familial Colorectal Cancer
Condition: Colorectal Neoplasms, Hereditary Nonpolyposis
Interventions: Other: Implementation aids;   Other: Control
12 Completed A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Carcinoma;   Colorectal Tumor
Interventions: Drug: enzastaurin;   Drug: irinotecan;   Drug: cetuximab
13 Recruiting CHROENDOHNPCC: Early Detection of Pre-Cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome
Condition: Colorectal Neoplasms, Hereditary Nonpolyposis
Intervention: Procedure: Colonoscopy with chromoscopy
14 Completed Study Evaluating MAC-321 in Colorectal Cancer
Conditions: Colorectal Neoplasms;   Colonic Neoplasms;   Rectal Neoplasms
Intervention: Drug: MAC-321
15 Completed Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance
Condition: Colorectal Neoplasms, Hereditary Nonpolyposis
Intervention: Procedure: Narrow Band Imaging
16 Active, not recruiting AMG 655/Panitumumab Combination Metastatic Colorectal Cancer Study
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer;   Oncology
Intervention: Drug: Panitumumab in combination with AMG 655
17 Active, not recruiting Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
Conditions: Cancer;   Metastatic Cancer;   Metastatic Colorectal Cancer;   Oncology;   Colon Cancer;   Colorectal Cancer;   Rectal Cancer
Intervention: Drug: panitumumab
18 Active, not recruiting Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Condition: Colorectal Neoplasms
Intervention: Drug: Aroplatin (Liposomal NDDP) in combination with capecitabine
19 Active, not recruiting A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Condition: Colorectal Neoplasms
Intervention: Drug: Aroplatin (Liposomal NDDP, L-NDDP)
20 Terminated Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery
Condition: Colorectal Neoplasms
Intervention: Drug: hMN14 (labetuzumab)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services